Kasinski awarded V Foundation Translational Grant to advance first-in-class targeted RNA therapies
PICR Deputy Director Andrea Kasinski has received a Translational Grant from the V Foundation for Cancer Research to advance novel microRNA (miRNA)-based cancer therapeutics. Her work uses engineered molecules to restore tumor-suppressing miRNAs and deliver them directly to cancer cells, overcoming key barriers in RNA medicine.
Research
Give Now
Events
Tyler Trent Pediatric Cancer Research Center
In creating the Tyler Trent Pediatric Cancer Research Center, the Purdue Institute for Cancer Research (PICR) brings together deep strengths in multiple research fields to fight pediatric cancers and to beat osteosarcoma, the rare bone cancer that took the life of beloved Purdue alumnus Tyler Trent.
Tyler’s parents, Tony and Kelly Trent, lead the way with their gift of $100,000 to continue the fight against cancer that Tyler began. To join in the fight, you can donate here to the center’s life-sustaining research.
Indiana research leads to life-extending treatment for prostate cancer
A collaboration between the Purdue Institute for Cancer Research and the IU Simon Comprehensive Cancer Center has helped deliver a life-extending therapy for patients with advanced prostate cancer.
Pluvicto™ — a targeted radiopharmaceutical therapy invented by Purdue researcher Philip Low and tested in clinical trials at Indiana University — is now giving patients like U.S. Army veteran Don Bryant new hope and time.
